Sequenex has announced a strategic partnership with MedTech Innovator, the world’s largest accelerator for medical technology companies, to support the growth of early- and mid-stage MedTech startups.
Through this collaboration, Sequenex will work closely with selected startups from the 2026 MedTech Innovator cohort, which is expected to include around 65 companies. The accelerator connects emerging innovators with industry leaders, investors, and mentors to help bring transformative healthcare solutions to market.
As part of the partnership, Sequenex will provide both financial support and technical expertise, focusing on software development for connected medical devices such as continuous glucose monitors (CGMs), biosensors, and wearable technologies.
Leveraging its NEX platform, Sequenex aims to help startups:
- Accelerate product development timelines
- Simplify integration and scalability
- Improve regulatory readiness
The company’s solutions are designed to address common challenges faced by MedTech startups, particularly in building compliant and scalable software for regulated healthcare environments.
According to Sequenex leadership, the partnership aligns with its mission to remove barriers in connected device innovation by enabling startups to bring products to market faster and more efficiently.
With this move, Sequenex strengthens its position in the MedTech ecosystem while advancing next-generation healthcare technologies.
